Citation: E. Saltiel, EFFICACY AND ECONOMIC CONCERNS REGARDING H-PYLORI TREATMENT IN THE MANAGED CARE SETTING, American journal of managed care, 4(4), 1998, pp. 265-271
Authors:
SHEFFIELD RE
SULLIVAN SD
SALTIEL E
NISHIMURA L
Citation: Re. Sheffield et al., COST COMPARISON OF RECOMBINANT-HUMAN-ERYTHROPOIETIN AND BLOOD-TRANSFUSION IN CANCER CHEMOTHERAPY-INDUCED ANEMIA, The Annals of pharmacotherapy, 31(1), 1997, pp. 15-22
Citation: E. Saltiel, CRITICAL PATHWAY EXPERIENCE AT CEDARS-SINAI MEDICAL-CENTER, American journal of health-system pharmacy, 52(10), 1995, pp. 1063-1068
Citation: E. Saltiel et al., A TEAM-APPROACH TO ADVERSE DRUG REACTION SURVEILLANCE - SUCCESS AT A TERTIARY CARE HOSPITAL, Hospital formulary, 30(4), 1995, pp. 226
Citation: E. Saltiel, ENOXAPARIN THE LOW-MOLECULAR-WEIGHT HEPARIN FOR PREVENTION OF POSTOPERATIVE THROMBOEMBOLIC COMPLICATIONS - COMMENT, The Annals of pharmacotherapy, 28(6), 1994, pp. 810-810
Citation: E. Saltiel et R. Wolfe, FOCUS ON PROCATEROL - A BETA(2)-SELECTIVE ADRENERGIC BRONCHODILATOR FOR USE IN ASTHMA AND OTHER BRONCHIAL AIRWAY DISORDERS, Hospital formulary, 29(9), 1994, pp. 621